What is BLK's health score?

BlackRock, Inc. (BLK) has a TradeApes health score of 63 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BLK's estimated fair value?

Based on our 5-year discounted cash flow model, BlackRock, Inc.'s estimated fair value is $755.49 per share, representing a -23.8% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is BLK undervalued or overvalued?

Our model currently rates BLK as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for BLK... Refresh in a moment for the full analysis.

BlackRock, Inc. (BLK)

Financials Overvalued medium healthy

$990.87

Updated: 2026-06-04

TradeApes Score

Financial Strength

75 Strong

Operating Trend

65 Healthy

Relative Value

60 Healthy

Capital Allocation

30 Weak

Risk

80 Strong

Est. Fair Value $755.49

DCF Upside -23.8%

Sector Rank #5827 of 6483

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.